Laura Nguyen, PA
Medical · Sugar Land, TXNPI 1710578190
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 294 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations.
Across 294 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$935
- Amgen$905
- Regeneron Healthcare Solutions, Inc.$669
- Johnson & Johnson$549
- LEO Pharma Inc.$490
- Sanofi$332
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,53598%
- Education$1032%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 57 | $935 |
| Amgen | 43 | $905 |
| Regeneron Healthcare Solutions, Inc. | 23 | $669 |
| Johnson & Johnson | 20 | $549 |
| LEO Pharma Inc. | 43 | $490 |
| Sanofi | 11 | $332 |
| Pfizer | 9 | $327 |
| UCB, Inc. | 7 | $283 |
| Arcutis Biotherapeutics, Inc. | 4 | $282 |
| Lilly USA, LLC | 9 | $270 |
| Bioventus LLC | 7 | $255 |
| E.r. Squibb & Sons, L.L.C. | 9 | $233 |
| Incyte Corporation | 2 | $146 |
| Galderma Laboratories, L.p. | 6 | $117 |
| Novartis | 4 | $89 |
| Organon | 7 | $70 |
| Genentech USA, Inc. | 3 | $67 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $61 |
| Medtronic | 1 | $59 |
| Abiomed | 2 | $54 |
| Dermavant Sciences, Inc. | 2 | $47 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $45 |
| Kerecis Limited | 1 | $43 |
| Mayne Pharma Commercial LLC | 4 | $33 |
| Nabriva Therapeutics, PLC | 2 | $32 |
| Convatec Inc. | 1 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Organogenesis Inc. | 1 | $28 |
| Boehringer Ingelheim | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Almirall LLC | 1 | $18 |
| Botanix SB Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Medline Industries LP | 1 | $14 |
| Axsome Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,638 in reported general payments places this provider in the 85th percentile of 1,490 medical providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $87,377 |
| Dupixent PenDupilumab | 15 | $57,854 |
| Acitretin | 14 | $4,890 |
| Clobetasol Propionate | 57 | $2,518 |
| Fluocinolone Acetonide | 17 | $1,215 |
| Metronidazole | 16 | $1,103 |
| Tretinoin | 13 | $965 |
| Ketoconazole | 83 | $923 |
| Hydrocortisone | 37 | $726 |
| Clindamycin Phosphate | 18 | $672 |
| Doxycycline Hyclate | 18 | $396 |
| Triamcinolone Acetonide | 73 | $384 |
| Ciclopirox | 16 | $322 |
| Mupirocin | 21 | $132 |
Paid to pharmacies, not to this prescriber.
Other medical in Sugar Land
- Jennifer HendersonSugar Land$19K
- Deanna WallaceSugar Land$17K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
- Shakira CabreraSan Antonio$116K
- Danny DeckardDallas$101K
- Courtney AldridgeSan Antonio$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.